Literature DB >> 19135917

Coagulase-negative staphylococcal infections.

Kathie L Rogers1, Paul D Fey, Mark E Rupp.   

Abstract

Coagulase-negative staphylococci (CNS) are differentiated from the closely related but more virulent Staphylococcus aureus by their inability to produce free coagulase. Currently, there are over 40 recognized species of CNS. These organisms typically reside on healthy human skin and mucus membranes, rarely cause disease, and are most frequently encountered by clinicians as contaminants of microbiological cultures. However, CNS have been increasingly recognized to cause clinically significant infections. The conversion of the CNS from symbiont to human pathogen has been a direct reflection of the use of indwelling medical devices. This article deals with the clinical syndromes, epidemiology, prevention, and management of infections caused by this unique group of organisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135917     DOI: 10.1016/j.idc.2008.10.001

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  137 in total

1.  Tuf gene sequence analysis has greater discriminatory power than 16S rRNA sequence analysis in identification of clinical isolates of coagulase-negative staphylococci.

Authors:  Sang Mee Hwang; Myoung Shin Kim; Kyoung Un Park; Junghan Song; Eui-Chong Kim
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

Review 2.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

3.  Implementation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Routine Clinical Laboratories Improves Identification of Coagulase-Negative Staphylococci and Reveals the Pathogenic Role of Staphylococcus lugdunensis.

Authors:  Xavier Argemi; Philippe Riegel; Thierry Lavigne; Nicolas Lefebvre; Nicolas Grandpré; Yves Hansmann; Benoit Jaulhac; Gilles Prévost; Frédéric Schramm
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 4.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

5.  Non-Native Peptides Capable of Pan-Activating the agr Quorum Sensing System across Multiple Specificity Groups of Staphylococcus epidermidis.

Authors:  Korbin H J West; Wenqi Shen; Emma L Eisenbraun; Tian Yang; Joseph K Vasquez; Alexander R Horswill; Helen E Blackwell
Journal:  ACS Chem Biol       Date:  2021-05-14       Impact factor: 5.100

6.  Transcriptional Regulation of icaADBC by both IcaR and TcaR in Staphylococcus epidermidis.

Authors:  Tra-My Hoang; C Zhou; J K Lindgren; M R Galac; B Corey; J E Endres; M E Olson; P D Fey
Journal:  J Bacteriol       Date:  2019-02-25       Impact factor: 3.490

7.  Spatiotemporal dynamics of complement C5a production within bacterial extracellular polymeric substance.

Authors:  Erin C Conrad; Yueh-Ya Hsu; David M Bortz; John G Younger
Journal:  J Innate Immun       Date:  2013-01-11       Impact factor: 7.349

8.  Complement c5a generation by staphylococcal biofilms.

Authors:  Ashley E Satorius; Jacob Szafranski; Derek Pyne; Mahesh Ganesan; Michael J Solomon; Duane W Newton; David M Bortz; John G Younger
Journal:  Shock       Date:  2013-04       Impact factor: 3.454

9.  Competition/antagonism associations of biofilm formation among Staphylococcus epidermidis Agr groups I, II, and III.

Authors:  Sergio Martínez-García; César I Ortiz-García; Marisa Cruz-Aguilar; Juan Carlos Zenteno; José Martin Murrieta-Coxca; Sonia Mayra Pérez-Tapia; Sandra Rodríguez-Martínez; Mario E Cancino-Diaz; Juan C Cancino-Diaz
Journal:  J Microbiol       Date:  2019-01-31       Impact factor: 3.422

Review 10.  Staphylococcus epidermidis--the 'accidental' pathogen.

Authors:  Michael Otto
Journal:  Nat Rev Microbiol       Date:  2009-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.